Skip to Content

Pfizer Matches Novo's $10 Billion Bid for Obesity Biotech Metsera

A competitive acquisition struggle highlights the strategic importance of biotechnology in the...
Key Metrics

15.8

Heat Index
  • Impact Level
    Medium
  • Scope Level
    Global
  • Last Update
    2025-11-12
Key Impacts
Positive Impacts (5)
Pfizer Inc.
Obesity & Metabolic Pharmaceuticals
Metsera
Bariatric Surgery Device Makers
S&P 500 Healthcare Index
Negative Impacts (2)
Novo Nordisk A/S
WeightWatchers International
Total impacts: 12 | Positive: 5 | Negative: 2
Event Overview

A competitive acquisition struggle highlights the strategic importance of biotechnology in the pharmaceutical industry, with companies vying for innovation and market share in the obesity treatment sector.

Collect Records
Pfizer Matches Novo's Bid for Obesity Biotech Company Metsera
2025-08-22 22:04

Pfizer has matched Novo's bid for the obesity biotech company Metsera, intensifying the ongoing takeover battle. The bid is valued at $10 billion.

Total records: 1
Allora Network Unveils Mainnet and ALLO Token, Pioneering Decentralized Model Coordination
The launch introduces a decentralized network for machine learning model coordination, enhancing...